Physician profile
Amjad Shaikh
NPI 1346589884
$3,672.39
in general payments reported to CMS, 2019-2025
32 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $770 · 2022: $993 · 2023: $911 · 2024: $564 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $600.48 | 2022-2023 | Harmony, Venaseal, Reveal Linq |
| Janssen Pharmaceuticals, INC | $444.32 | 2021-2024 | Xarelto |
| Astellas Pharma US INC | $391.86 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $361.95 | 2021-2025 | |
| Medicomp INC | $298.73 | 2022-2023 | Telepatch Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $247.94 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $191.82 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $190.21 | 2021-2023 | Verquvo, Belsomra |
| Pfizer INC. | $176.06 | 2021-2025 | |
| Kestra Medical Technology Services, INC. | $154.94 | 2024 | Assure Wcd |
| Abiomed | $68.24 | 2023 | Impella |
| Novo Nordisk INC | $67.24 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.93 | 2023-2024 | Lifevest |
| Boston Scientific Corporation | $45.00 | 2022-2025 | Varithena Administration Pack |
| Takeda Pharmaceuticals U.S.A., INC. | $37.25 | 2025 | Entyvio |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $31.93 | 2025 | Barostim Neo System |
| Abbott Laboratories | $30.91 | 2021-2023 | Confirm Rx |
| Kiniksa Pharmaceuticals International, Plc | $28.72 | 2024 | Arcalyst |
| Evoke Pharma, INC. | $24.87 | 2021 | |
| Photonicare INC | $23.47 | 2024 | Otosight Middle Ear Scope |
| Alnylam Pharmaceuticals INC. | $22.81 | 2021 | |
| Ge Healthcare | $22.00 | 2025 | |
| Amarin Pharma, INC. | $21.76 | 2021 | |
| Daiichi Sankyo INC. | $20.04 | 2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $18.59 | 2025 | |
| Atricure, INC. | $18.54 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.58 | 2021 | |
| Impulse Dynamics (USA) INC. | $17.39 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Esperion Therapeutics, INC. | $13.55 | 2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $12.77 | 2021 | |
| Genentech USA, INC. | $8.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amjad Shaikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.